We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+20.76%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$2.03B
AUM Growth
+$568M
Cap. Flow
+$260M
Cap. Flow %
12.83%
Top 10 Hldgs %
33.97%
Holding
451
New
80
Increased
96
Reduced
187
Closed
25

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$81.4M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$51.1M
3
BMY icon
Bristol-Myers Squibb
BMY
+$31.5M
4
ABT icon
Abbott
ABT
+$22.2M
5
AMZN icon
Amazon
AMZN
+$20.6M

Sector Composition

Rank Sector Weight
1 Healthcare 23.98%
2 Technology 15.22%
3 Financials 13.51%
4 Energy 9.48%
5 Industrials 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
26
Amazon
AMZN
$2.48T
$21M 1.04%
+128,840
New +$20.6M
UL icon
27
Unilever
UL
$144B
$19.8M 0.98%
291,851
+149,991
+106% +$10.2M
ABBV icon
28
AbbVie
ABBV
$465B
$19.4M 0.96%
181,117
+9,569
+6% +$920K
CSCO icon
29
Cisco
CSCO
$456B
$18.6M 0.92%
416,005
+44,449
+12% +$1.83M
CNCE
30
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$17.2M 0.85%
1,362,203
-1,400
-0.1% -$16K
BAC icon
31
Bank of America
BAC
$439B
$16.6M 0.82%
+546,145
New +$14.6M
CACC icon
32
Credit Acceptance
CACC
$5.84B
$16.2M 0.8%
46,794
-100
-0.2% -$32.7K
GL icon
33
Globe Life
GL
$13.9B
$15.7M 0.78%
+165,400
New +$14.7M
DRRX
34
DELISTED
DURECT Corp
DRRX
$15.2M 0.75%
736,586
-15,555
-2% -$296K
CPRT icon
35
Copart
CPRT
$28.4B
$14.9M 0.73%
467,352
-7,600
-2% -$221K
C icon
36
Citigroup
C
$222B
$14.7M 0.73%
238,387
+10,204
+4% +$519K
EMR icon
37
Emerson Electric
EMR
$85B
$14.1M 0.7%
175,283
-2,607
-1% -$194K
KO icon
38
Coca-Cola
KO
$380B
$14M 0.69%
255,879
-1,329
-0.5% -$68.7K
UNP icon
39
Union Pacific
UNP
$175B
$13.8M 0.68%
66,134
-717
-1% -$143K
PEP icon
40
PepsiCo
PEP
$195B
$13.4M 0.66%
90,195
-1,237
-1% -$176K
VZ icon
41
Verizon
VZ
$201B
$13.1M 0.64%
222,347
-1,828
-0.8% -$109K
RTX icon
42
RTX Corp
RTX
$295B
$12.7M 0.63%
+178,142
New +$11.7M
ORCL icon
43
Oracle
ORCL
$346B
$12.6M 0.62%
194,919
-5,596
-3% -$333K
DCO icon
44
Ducommun
DCO
$2.68B
$11.1M 0.55%
206,707
+2,966
+1% +$128K
ALSN icon
45
Allison Transmission
ALSN
$10B
$11M 0.54%
254,119
-24,212
-9% -$974K
MED icon
46
Medifast
MED
$108M
$9.43M 0.47%
48,006
-881
-2% -$156K
JCI icon
47
Johnson Controls International
JCI
$85.6B
$9.26M 0.46%
198,732
-13,993
-7% -$622K
CMPR icon
48
Cimpress
CMPR
$2.43B
$8.83M 0.44%
100,643
-910
-0.9% -$78.2K
CB icon
49
Chubb
CB
$141B
$8.7M 0.43%
56,515
-6,982
-11% -$979K
TMUS icon
50
T-Mobile US
TMUS
$196B
$8.68M 0.43%
64,353
-2,221
-3% -$274K

Similar funds

Ingalls & Snyder LLC's Q4 2020 Portfolio in Review

As of Q4 2020, Ingalls & Snyder LLC held 451 positions worth $2.03B, up 39% from $1.46B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ingalls & Snyder LLC deployed $260M of net new capital in Q4 2020, opening 80 new positions and adding to 96 existing holdings. Its largest new stake was Apple: 676,484 shares worth $89.8M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Fortuna Silver Mines, an estimated $10.3M trimmed.

  • Ingalls & Snyder LLC's largest Q4 2020 buy was Apple: 676,484 shares worth $89.8M.
  • Ingalls & Snyder LLC added most to Unilever in Q4 2020, an estimated $10.2M increase.
  • Ingalls & Snyder LLC's biggest Q4 2020 reduction was Fortuna Silver Mines, cutting an estimated $10.3M.
  • Ingalls & Snyder LLC fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $5.65M.
  • Ingalls & Snyder LLC's ten largest holdings make up 34% of its $2.03B portfolio in Q4 2020.
  • Ingalls & Snyder LLC opened 80 new positions and closed 25 in Q4 2020.
  • Ingalls & Snyder LLC's portfolio value rose 39% quarter-over-quarter to $2.03B.

Based on Ingalls & Snyder LLC's 13F filing for Q4 2020, filed 27 Jan 2021.